1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RGS9 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA COQ8A CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA ATP6V1B2 CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA UBL3 CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA ITGB2 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA TRPM2 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA OSBPL11 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA B3GNT8 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA OVOL1 CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA ANKRD13D CTRPv2 pan-cancer AAC 0.16 2e-05
Download CSV